Recent studies have shown that DDX17 participates in the pathogenesis and progression of various tumors, such as colorectal cancer, liver cancer, pancreatic ductal adenocarcinoma, and lung adenocarcinoma, and is also related to these tumors’ survival and prognosis [9, 27–29]. Here, DDX17 is linked to liver cancer.